Bacterial agents in spondyloarthritis: a destiny from diversity?

• Published in: Best practice & research. Clinical rheumatology Vol. 24; no. 5; pp. 701 - 714
• Main Author: Carter, John D., MD
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.10.2010
• Subjects: ankylosing spondylitis; Arthritis, Reactive - microbiology; Arthritis, Reactive - physiopathology; Humans; inflammatory bowel disease related arthritis; psoriatic arthritis; reactive arthritis; Rheumatology; Spondylarthritis - microbiology; Spondylarthritis - physiopathology; spondyloarthritis; spondyloarthritis; reactive arthritis; inflammatory bowel disease related arthritis; psoriatic arthritis; ankylosing spondylitis
• ISSN: 1521-6942; 1532-1770
• DOI: 10.1016/j.berh.2010.05.002

The spondyloarthritides (SpAs) are a group of diseases that share clinical, radiographic and laboratory features; these arthritides also display a tendency for family aggregation. Given the intimate relationship that these types of arthritis share, it suggests that the SpAs might share a common aetiology. Of all the SpAs, the role of bacteria is most clearly defined in reactive arthritis. Tremendous recent insights into the pathophysiology of reactive arthritis have been made, demonstrating that the causative bacteria play a much more complex role than previously thought. The bacteria that are proven to cause reactive arthritis, one of the five types of SpA, will be reviewed and their role in the pathophysiology of reactive arthritis will be examined. The speculative data suggesting links between various other bacteria and the other types of SpAs will be critically analysed. Although these data are not definitive, when viewed using the paradigm that the SpAs might actually represent a common end point from several diverse starting points, they are provocative, suggesting that bacteria might, indeed, be aetiological for the entire group of SpAs.